Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
dLyYnaeLQGZcGgZg
